Latest profit margin for Progenity: -1787.93% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ FollowAs of Sep 2024
Trailing 12 months ending Sep 2024
Progenity (PROG) currently reports a profit margin of -1787.93% as of September 2024. That compares with -704155.56% in the prior-year period — up 99.7% year over year. That is below the Healthcare sector average of 21.34%. Use the charts on this page to explore Progenity's profit margin history and peer comparisons.
Progenity's profit margin increased from -704155.56% to -1787.93% — a 99.7% year-over-year increase (period ending September 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Progenity's profit margin of -1787.93% is lower than the Healthcare sector average of 21.34%. That is roughly 8480.2% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but Progenity's current -1787.93% should be judged against Healthcare norms (sector average: 21.34%) and against PROG's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of -1787.93%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 21.34%. From there, open related valuation or income-statement pages for Progenity, and consider following PROG for alerts when major investors trade the stock.